Two HIFs may be better than one
Open Access
- 1 April 2002
- journal article
- previews
- Published by Elsevier in Cancer Cell
- Vol. 1 (3) , 211-213
- https://doi.org/10.1016/s1535-6108(02)00048-x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The contribution of VHL substrate binding and HIF1-α to the phenotype of VHL loss in renal cell carcinomaCancer Cell, 2002
- Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau proteinCancer Cell, 2002
- Hypoxia-inducible factor 1 alpha (HIF-1α) gene expression in human ovarian carcinomaCancer Letters, 2002
- Renal cancer: molecular mechanisms and newer therapeutic optionsCurrent Opinion in Nephrology and Hypertension, 2002
- The von Hippel–Lindau Tumor Suppressor GeneExperimental Cell Research, 2001
- Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesisNature, 1998
- HIF-1alpha is required for solid tumor formation and embryonic vascularizationThe EMBO Journal, 1998
- Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growthProceedings of the National Academy of Sciences, 1997
- Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumoursNature, 1996
- Tumour suppression by the human von Hippel-Lindau gene productNature Medicine, 1995